GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Change In Other Working Capital

Alkermes (STU:8AK) Change In Other Working Capital : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Alkermes Change In Other Working Capital?

Alkermes's Change In Other Working Capital for the quarter that ended in Mar. 2024 was €-1 Mil. It means Alkermes's Other Working Capital declined by €1 Mil from Dec. 2023 to Mar. 2024 .

Alkermes's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was €2 Mil. It means Alkermes's Other Working Capital increased by €2 Mil from Dec. 2022 to Dec. 2023 .

Alkermes Change In Other Working Capital Historical Data

The historical data trend for Alkermes's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes Change In Other Working Capital Chart

Alkermes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.90 4.53 7.26 -10.44 2.43

Alkermes Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 -26.19 19.87 7.74 -0.97

Alkermes Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkermes Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Alkermes's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkermes (STU:8AK) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (STU:8AK) » Definitions » Change In Other Working Capital
Comparable Companies
ALVO PRGO PBH LNTH DCPH AMPH AMRX TARO TLRY AVDL XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
ALKS:USA 8AK:Germany
Address
1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Website
https://www.alkermes.com
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

Alkermes (STU:8AK) Headlines

No Headlines